Human podocyte depletion in association with older age and hypertension

American Journal of Physiology - Renal Physiology

Volumn 310, Issue 7, 2016, Pages F656-F668

  Puelles, Victor G ^a   Cullen McEwen, Luise A ^a   Taylor, Georgina E ^a   Li, Jinhua ^a   Hughson, Michael D ^b   Kerr, Peter G ^c   Hoy, Wendy E ^d   Bertram, John F ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c MONASH MEDICAL CENTRE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Hypertension; Older age; Podocyte depletion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SYNAPTOPODIN; THIAZIDE DIURETIC AGENT; WT1 PROTEIN;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTERIOSCLEROSIS; ARTICLE; AUTOPSY; BODY MASS; BODY SURFACE; CELL LOSS; CELL VOLUME; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPEAN AMERICAN; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY HYPERTROPHY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PODOCYTE; PODOCYTE DEPLETION; PRIORITY JOURNAL; STEREOLOGY; YOUNG ADULT; ADOLESCENT; AGING; CELL COUNT; GLOMERULUS; PATHOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGING; CELL COUNT; HUMANS; HYPERTENSION; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PODOCYTES; YOUNG ADULT;

EID: 84981242567     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00497.2015     Document Type: Article

References (67)

1. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, Frye B, Elger M, Kriz W, Floege J, Moeller MJ. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 20: 333-343, 2009
2. Bariety J, Mandet C, Hill GS, Bruneval P. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 17: 2770-2780, 2006
3. Berger K, Moeller MJ. Podocytopenia, parietal epithelial cells and glomerulosclerosis. Nephrol Dial Transplant 29: 948-950, 2014
4. Berger K, Schulte K, Boor P, Kuppe C, van Kuppevelt TH, Floege J, Smeets B, Moeller MJ. The regenerative potential of parietal epithelial cells in adult mice. J Am Soc Nephrol 25: 693-705, 2014
5. Bertram JF. Analyzing renal glomeruli with the new stereology. Int Rev Cytol 161: 111-172, 1995
6. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol Renal Fluid Electrolyte Physiol 249: F324-F337, 1985
7. Cahill MM, Ryan GB, Bertram JF. Biphasic glomerular hypertrophy in rats administered puromycin aminonucleoside. Kidney Int 50: 768-775, 1996
8. Collins TJ. ImageJ for microscopy. Biotechniques 43, Suppl 1: 25-30, 2007
9. Cusumano AM, Bodkin NL, Hansen BC, Iotti R, Owens J, Klotman PE, Kopp JB. Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis 40: 1075-1085, 2002
10. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52: 1031-1035, 2003
11. Durvasula RV, Shankland SJ. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens 15: 1-7, 2006
12. Elsherbiny HE, Alexander MP, Kremers WK, Park WD, Poggio ED, Prieto M, Lieske JC, Rule AD. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Clin J Am Soc Nephrol 9: 1892-1902, 2014
13. Eng DG, Sunseri MW, Kaverina NV, Roeder SS, Pippin JW, Shankland SJ. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int 88: 999-1012, 2015
14. Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R, Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D, Shedden KA, Inoki K, Wiggins RC. Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 23: 1351-1363, 2012
15. Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int 82: 270-277, 2012
16. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263, 1987
17. Guo M, Ricardo SD, Deane JA, Shi M, Cullen-McEwen L, Bertram JF. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat 207: 813-821, 2005
18. Hodgin JB, Bitzer M, Wickman L, Afshinnia F, Wang SQ, O’Connor C, Yang Y, Meadowbrooke C, Chowdhury M, Kikuchi M, Wiggins JE, Wiggins RC. Glomerular aging and focal global glomerulosclerosis: a podometric perspective. J Am Soc Nephrol 26: 3162-3178, 2015
19. Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 2003: S31-S37, 2003
20. Hoy WE, Hughson MD, Zimanyi M, Samuel T, Douglas-Denton R, Holden L, Mott S, Bertram JF. Distribution of volumes of individual glomeruli in kidneys at autopsy: association with age, nephron number, birth weight and body mass index. Clin Nephrol 74, Suppl 1: S105-S112, 2010
21. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 63: 2113-2122, 2003
22. Hughson MD, Hoy WE, Douglas-Denton RN, Zimanyi MA, Bertram JF. Towards a definition of glomerulomegaly: clinical-pathological and methodological considerations. Nephrol Dial Transplant 26: 2202-2208, 2011
23. Hughson MD, Puelles VG, Hoy WE, Douglas-Denton RN, Mott SA, Bertram JF. Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race. Nephrol Dial Transplant 29: 1399-1409, 2013
24. Ijpelaar DH, Schulz A, Koop K, Schlesener M, Bruijn JA, Kerjaschki D, Kreutz R, de Heer E. Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Fromter rats. Am J Physiol Renal Physiol 294: F758-F767, 2008
25. Jefferson JA, Alpers CE, Shankland SJ. Podocyte biology for the bedside. Am J Kidney Dis 58: 835-845, 2011
26. Jefferson JA, Nelson PJ, Najafian B, Shankland SJ. Podocyte disorders: core curriculum 2011. Am J Kidney Dis 58: 666-677, 2011
27. Kremers WK, Denic A, Lieske JC, Alexander MP, Kaushik V, Elsherbiny HE, Chakkera HA, Poggio ED, Rule AD. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transplant 30: 2034-2039, 2015
28. Kriz W. Glomerular diseases: podocyte hypertrophy mismatch and glomerular disease. Nat Rev Nephrol 8: 618-619, 2012
29. Kriz W, Elger M, Nagata M, Kretzler M, Uiker S, Koeppen-Hageman I, Tenschert S, Lemley KV. The role of podocytes in the development of glomerular sclerosis. Kidney Int Suppl 45: S64-S72, 1994
30. Kriz W, Hosser H, Hähnel B, Simons JL, Provoost AP. Development of vascular pole-associated glomerulosclerosis in the Fawn-hooded rat. J Am Soc Nephrol 9: 381-396, 1998
31. Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 26: 258-269, 2015
32. Lasagni L, Angelotti ML, Ronconi E, Lombardi D, Nardi S, Peired A, Becherucci F, Mazzinghi B, Sisti A, Romoli S, Burger A, Schaefer B, Buccoliero A, Lazzeri E, Romagnani P. Podocyte regeneration driven by renal progenitors determines glomerular disease remission and can be pharmacologically enhanced. Stem Cell Rep 5: 248-263, 2015
33. Lee HS, Lim SD. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis. Clin Nephrol 44: 349-355, 1995
34. Lemley KV, Bertram JF, Nicholas SB, White K. Estimation of glomerular podocyte number: a selection of valid methods. J Am Soc Nephrol 24: 1193-1202, 2013
35. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61: 1475-1485, 2002
36. Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382: 273-283, 2013
37. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts longterm urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344, 1999
38. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002
39. Nagata M, Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42: 148-160, 1992
40. Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND. The Wilms’ tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 13: 463-471, 2004
41. Noel LH. Morphological features of primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant 14, Suppl 3: 53-57, 1999
42. Nyberg E, Bohman SO, Berg U. Glomerular volume and renal function in children with different types of the nephrotic syndrome. Pediatr Nephrol 8: 285-289, 1994
43. Olivetti G, Anversa P, Melissari M, Loud AV. Morphometry of the renal corpuscle during postnatal growth and compensatory hypertrophy. Kidney Int 17: 438-454, 1980
44. Osterby R, Gundersen HJ, Nyberg G, Aurell M. Advanced diabetic glomerulopathy. Quantitative structural characterization of nonoccluded glomeruli. Diabetes 36: 612-619, 1987
45. Osterby R, Parving HH, Hommel E, Jørgensen HE, Løkkegaard H. Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes 39: 1057-1063, 1990
46. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997
47. Puelles VG, Douglas-Denton RN, Cullen-McEwen LA, Li J, Hughson MD, Hoy WE, Kerr PG, Bertram JF. Podocyte number in children and adults: associations with glomerular size and numbers of other glomerular resident cells. J Am Soc Nephrol 26: 2277-2288, 2015
48. Puelles VG, Douglas-Denton RN, Cullen-McEwen L, McNamara BJ, Salih F, Li J, Hughson MD, Hoy WE, Nyengaard JR, Bertram JF. Design-based stereological methods for estimating numbers of glomerular podocytes. Ann Anat 196: 48-56, 2014
49. Puelles VG, Hoy WE, Hughson MD, Diouf B, Douglas-Denton RN, Bertram JF. Glomerular number and size variability and risk for kidney disease. Curr Opin Nephrol Hypertens 20: 7-15, 2011
50. Puelles VG, Zimanyi MA, Samuel T, Hughson MD, Douglas-Denton RN, Bertram JF, Armitage JA. Estimating individual glomerular volume in the human kidney: clinical perspectives. Nephrol Dial Transplant 27: 1880-1888, 2012
51. Roeder SS, Stefanska A, Eng DG, Kaverina N, Sunseri MW, McNicholas BA, Rabinovitch P, Engel FB, Daniel C, Amann K, Lichtnekert J, Pippin JW, Shankland SJ. Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age. Am J Physiol Renal Physiol 309: F164-F178, 2015
52. Samuel T, Hoy WE, Douglas-Denton R, Hughson MD, Bertram JF. Determinants of glomerular volume in different cortical zones of the human kidney. J Am Soc Nephrol 16: 3102-3109, 2005
53. Saran R, Shahinian V. CKD: a pandemic calling for concerted public health action. Adv Chronic Kidney Dis 17: 213-214, 2010
54. Shankland SJ. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006
55. Shankland SJ, Anders HJ, Romagnani P. Glomerular parietal epithelial cells in kidney physiology, pathology, and repair. Curr Opin Nephrol Hypertens 22: 302-309, 2013
56. Steffes MW, Schmidt D, McCrery R, Basgen JM; International Diabetic Nephropathy Study Group. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113, 2001
57. Stevens LA, Levey AS. Current status and future perspectives for CKD testing. Am J Kidney Dis 53, Suppl 3: S17-S26, 2009
58. Su J, Li SJ, Chen ZH, Zeng CH, Zhou H, Li LS, Liu ZH. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms’ tumor-1 protein used as a podocyte marker. Diabetes Res Clin Pract 87: 167-175, 2010
59. Suzuki J, Yoshikawa N, Nakamura H. A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis. Pediatr Nephrol 8: 416-419, 1994
60. Wang G, Lai FM, Kwan BC, Lai KB, Chow KM, Li PK, Szeto CC. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 22: 300-306, 2009
61. Wanner N, Hartleben B, Herbach N, Goedel M, Stickel N, Zeiser R, Walz G, Moeller MJ, Grahammer F, Huber TB. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol 25: 707-716, 2014
62. Wei P, Lane PH, Lane JT, Padanilam BJ, Sansom SC. Glomerular structural and functional changes in a high-fat diet mouse model of early-stage type 2 diabetes. Diabetologia 47: 1541-1549, 2004
63. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005
64. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
65. Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 63: 236-243, 2014
66. Young RJ, Hoy WE, Kincaid-Smith P, Seymour AE, Bertram JF. Glomerular size and glomerulosclerosis in Australian aborigines. Am J Kidney Dis 36: 481-489, 2000
67. Zimanyi MA, Hoy WE, Douglas-Denton RN, Hughson MD, Holden LM, Bertram JF. Nephron number and individual glomerular volumes in male Caucasian and African American subjects. Nephrol Dial Transplant 24: 2428-2433, 2009.